| Product Code: ETC9959549 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Artificial Blood Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Artificial Blood Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Artificial Blood Market - Industry Life Cycle |
3.4 United States (US) Artificial Blood Market - Porter's Five Forces |
3.5 United States (US) Artificial Blood Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United States (US) Artificial Blood Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
3.7 United States (US) Artificial Blood Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
3.8 United States (US) Artificial Blood Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 United States (US) Artificial Blood Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as cardiovascular disorders and anemia driving the demand for artificial blood. |
4.2.2 Technological advancements in the field of biotechnology and medical research leading to the development of improved artificial blood products. |
4.2.3 Rising number of trauma cases and emergency situations where artificial blood can be crucial in saving lives. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approvals for artificial blood products leading to a slow market adoption. |
4.3.2 Concerns regarding the safety and efficacy of artificial blood compared to traditional blood transfusions. |
4.3.3 High cost of research and development associated with artificial blood products hindering market growth. |
5 United States (US) Artificial Blood Market Trends |
6 United States (US) Artificial Blood Market, By Types |
6.1 United States (US) Artificial Blood Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Artificial Blood Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United States (US) Artificial Blood Market Revenues & Volume, By Anemia, 2021- 2031F |
6.1.4 United States (US) Artificial Blood Market Revenues & Volume, By Organ transplant, 2021- 2031F |
6.1.5 United States (US) Artificial Blood Market Revenues & Volume, By Injuries, 2021- 2031F |
6.1.6 United States (US) Artificial Blood Market Revenues & Volume, By Cardiovascular diseases, 2021- 2031F |
6.1.7 United States (US) Artificial Blood Market Revenues & Volume, By Maternal conditions, 2021- 2031F |
6.1.8 United States (US) Artificial Blood Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Artificial Blood Market, By Distribution channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Artificial Blood Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 United States (US) Artificial Blood Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 United States (US) Artificial Blood Market Revenues & Volume, By Blood banks, 2021- 2031F |
6.3 United States (US) Artificial Blood Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Artificial Blood Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Artificial Blood Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 United States (US) Artificial Blood Market Revenues & Volume, By Blood banks, 2021- 2031F |
6.4 United States (US) Artificial Blood Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Artificial Blood Market Revenues & Volume, By Hemoglobin-based oxygen carriers, 2021- 2031F |
6.4.3 United States (US) Artificial Blood Market Revenues & Volume, By Perfluorocarbon emulsion, 2021- 2031F |
7 United States (US) Artificial Blood Market Import-Export Trade Statistics |
7.1 United States (US) Artificial Blood Market Export to Major Countries |
7.2 United States (US) Artificial Blood Market Imports from Major Countries |
8 United States (US) Artificial Blood Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on artificial blood products. |
8.2 Adoption rate of artificial blood products in emergency medical services and trauma centers. |
8.3 Investment flow into companies and research institutions working on artificial blood technology. |
9 United States (US) Artificial Blood Market - Opportunity Assessment |
9.1 United States (US) Artificial Blood Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United States (US) Artificial Blood Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
9.3 United States (US) Artificial Blood Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
9.4 United States (US) Artificial Blood Market Opportunity Assessment, By Product, 2021 & 2031F |
10 United States (US) Artificial Blood Market - Competitive Landscape |
10.1 United States (US) Artificial Blood Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Artificial Blood Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here